Format

Send to

Choose Destination
Haemostasis. 1990;20(5):276-88.

Development of a sensitive and rapid chromogenic factor IX assay for clinical use.

Author information

1
Department of Biochemistry, University of Limburg, Maastricht, The Netherlands.

Abstract

A chromogenic factor IX assay is developed which requires only two time-dependent steps. Diluted plasma is mixed with a reagent containing factors VIII and X. The reaction is started by addition of a reagent containing factor XIa, thrombin, CaCl2, and phospholipids. Then factor XIa activates factor IX if present, thrombin activates factor VIII, and subsequently the complete factor X activating complex (factor IXa, factor VIIIa, Ca ions, and phospholipids) rapidly activates factor X. Finally, ethylenediaminetetraacetic acid plus a chromogenic substrate are added to stop the reaction and to measure formed factor Xa. Factor Xa formation is proportional to the plasma factor IX concentration (from 0 to 140%). The two reagents needed for the assay are stable at room temperature during a whole working day and for 3 h at 37 degrees C. A new isolation procedure for factor VIII is described. Factor VIII is purified from bovine plasma in a few steps with a yield of 20% and a 8,000-fold purification.

PMID:
2127037
DOI:
10.1159/000216139
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center